Pharmaceutical Information |
Drug Name |
Benzylpenicilloyl polylysine |
Drug ID |
BADD_D00251 |
Description |
Benzylpenicilloyl polylysine is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. The quantitation of in vitro IgE antibodies to the benzylpenicilloyl determinant is a useful tool for evaluating allergic subjects. |
Indications and Usage |
For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G). |
Marketing Status |
Not Available |
ATC Code |
Not Available |
DrugBank ID |
DB00895
|
KEGG ID |
D03095
|
MeSH ID |
C509029
|
PubChem ID |
45266800
|
TTD Drug ID |
D0J7TM
|
NDC Product Code |
49471-001 |
Synonyms |
benzylpenicilloyl G polylysine | BPO-oligolysine | benzylpenicilloyl-G-polylysine |
|
Chemical Information |
Molecular Formula |
C28H46N6O8S |
CAS Registry Number |
31855-75-1 |
SMILES |
CC1(C(NC(S1)C(C(=O)NCCCCC(C(=O)O)N)NC(=O)CC2=CC=CC=C2)C(=O)O)C.C(CCN)CC(C(=O)O)N |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|